Literature DB >> 6894401

Phase II study of AMSA in patients with metastatic malignant melanoma.

A M Houghton, F Camacho, R Wittes, C W Young.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6894401

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  2 in total

1.  Human tissue distribution of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (NSC 141549, AMSA).

Authors:  D J Stewart; G Zhengang; K Lu; N Savaraj; L G Feun; M Luna; R S Benjamin; M J Keating; T L Loo
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

2.  Phase II study of AMSA alone and in combination with DTIC in patients with metastatic melanoma.

Authors:  A Polyzos; S S Legha; A M Burgess; R S Benjamin; G P Bodey
Journal:  Invest New Drugs       Date:  1988-04       Impact factor: 3.850
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.